BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 22106360)

  • 1. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing.
    Nielsen JC; Thomsen PE; Højberg S; Møller M; Riahi S; Dalsgaard D; Mortensen LS; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR;
    Europace; 2012 May; 14(5):682-9. PubMed ID: 22106360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.
    Sweeney MO; Hellkamp AS; Ellenbogen KA; Greenspon AJ; Freedman RA; Lee KL; Lamas GA;
    Circulation; 2003 Jun; 107(23):2932-7. PubMed ID: 12782566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does atrial pacing lead to atrial fibrillation in patients with sick sinus syndrome? Insights from the DANPACE trial.
    Hjortshøj S; Riahi S; Nielsen JC; Skjøth F; Lundbye-Christensen S; Andersen HR;
    Europace; 2014 Feb; 16(2):241-5. PubMed ID: 24169735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
    Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
    Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome.
    Nielsen JC; Thomsen PE; Højberg S; Møller M; Vesterlund T; Dalsgaard D; Mortensen LS; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR;
    Eur Heart J; 2011 Mar; 32(6):686-96. PubMed ID: 21300730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A; Senatore G; Donnici G; Turco P; Romano E; Gazzola C; Stabile G
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single lead atrial vs. dual chamber pacing in sick sinus syndrome: extended register-based follow-up in the DANPACE trial.
    Brandt NH; Kirkfeldt RE; Nielsen JC; Mortensen LS; Jensen GVH; Johansen JB; Haugan K
    Europace; 2017 Dec; 19(12):1981-1987. PubMed ID: 28039212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinus and paced P wave duration and dispersion as predictors of atrial fibrillation after pacemaker implantation in patients with isolated sick sinus syndrome.
    Kristensen L; Nielsen JC; Mortensen PT; Christensen PD; Vesterlund T; Pedersen AK; Andersen HR
    Pacing Clin Electrophysiol; 2004 May; 27(5):606-14. PubMed ID: 15125716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near elimination of ventricular pacing in SafeR mode compared to DDD modes: a randomized study of 422 patients.
    Davy JM; Hoffmann E; Frey A; Jocham K; Rossi S; Dupuis JM; Frabetti L; Ducloux P; Prades E; Jauvert G
    Pacing Clin Electrophysiol; 2012 Apr; 35(4):392-402. PubMed ID: 22309303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome: Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) Study.
    Lau CP; Tachapong N; Wang CC; Wang JF; Abe H; Kong CW; Liew R; Shin DG; Padeletti L; Kim YH; Omar R; Jirarojanakorn K; Kim YN; Chen MC; Sriratanasathavorn C; Munawar M; Kam R; Chen JY; Cho YK; Li YG; Wu SL; Bailleul C; Tse HF;
    Circulation; 2013 Aug; 128(7):687-93. PubMed ID: 23868858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure in patients with sick sinus syndrome treated with single lead atrial or dual-chamber pacing: no association with pacing mode or right ventricular pacing site.
    Riahi S; Nielsen JC; Hjortshøj S; Thomsen PE; Højberg S; Møller M; Dalsgaard D; Nielsen T; Asklund M; Friis EV; Christensen PD; Simonsen EH; Eriksen UH; Jensen GV; Svendsen JH; Toff WD; Healey JS; Andersen HR;
    Europace; 2012 Oct; 14(10):1475-82. PubMed ID: 22447958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of atrial and ventricular pacing on the incidence of atrial fibrillation: a meta-analysis.
    Elkayam LU; Koehler JL; Sheldon TJ; Glotzer TV; Rosenthal LS; Lamas GA
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1593-9. PubMed ID: 21819434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.
    Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M
    Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome.
    Kristensen L; Nielsen JC; Mortensen PT; Pedersen OL; Pedersen AK; Andersen HR
    Heart; 2004 Jun; 90(6):661-6. PubMed ID: 15145874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.
    Sweeney MO; Bank AJ; Nsah E; Koullick M; Zeng QC; Hettrick D; Sheldon T; Lamas GA;
    N Engl J Med; 2007 Sep; 357(10):1000-8. PubMed ID: 17804844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A preliminary study on the role of anti-atrial fibrillation pacemaker in the prevention of atrial tachyarrhythmia].
    Yang JF; Tong JB; Wang ZL; Zhou T; Li M; Wu SJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):824-6. PubMed ID: 16266459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation.
    Lam CT; Lau CP; Leung SK; Tse HF; Lee KL; Tang MO; Tsang V
    Europace; 2000 Oct; 2(4):286-91. PubMed ID: 11194594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome.
    Nielsen JC; Pedersen AK; Mortensen PT; Andersen HR
    Europace; 1999 Apr; 1(2):113-20. PubMed ID: 11228853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.